The FDA Process from the Perspective of a Cytopathologist in Industry

Publisher： Karger

E-ISSN： 1938-2650|40|1|141-142

ISSN： 0001-5547

Source： Acta Cytologica, Vol.40, Iss.1, 2011-09, pp. : 141-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Thoughts on the Cytopathologist and Cell Culture

By  

Acta Cytologica, Vol. 43, Iss. 6, 2011-08 ,pp. : 983-984

Karger

Access to resources Recommend Favorite

The FDA Review Process: Obtaining Premarket Approval for the PAPNET Testing System

By  

Acta Cytologica, Vol. 40, Iss. 1, 2011-09 ,pp. : 138-140

Karger

Access to resources Recommend Favorite

A Quality Control Study on Cytotechnologist-Cytopathologist Concordance and Its Relationship to the Number of Dots on the Slide

By  

Acta Cytologica, Vol. 53, Iss. 6, 2011-02 ,pp. : 653-658

Karger

Access to resources Recommend Favorite

FDA-NCI Workshop on Tumor Vaccines

By Przepiorka D  

Cytotherapy, Vol. 1, Iss. 2, 1999-01 ,pp. : 159-159

Ashgate Publishing Ltd

Access to resources Recommend Favorite

FDA's New Regulatory Paradigms for in vitro Diagnostic Devices

By Robinowitz M   Gutman SI  

Cytotherapy, Vol. 1, Iss. 4, 1999-01 ,pp. : 353-357

Ashgate Publishing Ltd

Access to resources Recommend Favorite